Search results
GSK takes full control of flu vaccine programme in €1.45bn deal
Proactive Financial News· 15 hours agoGSK PLC (LSE:GSK, NYSE:GSK) said it will take effective control of a collaboration to create new...
GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots
Bloomberg· 16 hours agoHave a confidential tip for our reporters? GSK Plc agreed to pay as much as €1.4 billion ($1.5...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement (1)
PharmiWeb· 15 hours agoLONDON, UK, TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / GSK plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq:CVAC) today ...
GSK buys full rights to make COVID, influenza vaccines from CureVac
Reuters· 15 hours agoGSK has bought from CureVac 5CV.DE, CVAC.O the full rights to develop and manufacture vaccine...